Free Alerts   Login
Health Care › Industrial Instruments For Measurement, Display, And Control

SENS Stock Price Correlated With Senseonics Holdings Financials

SENS Stock Price vs. Quarterly
SENS
Income Statement
Cash Flow
Balance Sheet

SENS Income Statement

Enable JavaScript and reload
Revenue, Net:
Revenue Per Share:
Cost of Goods & Services Sold:
Gross Profit:
Selling, General & Admin Expense:
Research & Development Expense:
Total Operating Expenses:
Operating Income:
Income Taxes:
Net Income:
Earnings Per Share, Diluted:
Earnings Per Share, Basic:
Shares Outstanding, Basic Avg:
Shares Outstanding, Diluted Avg:
Common Stock Shares Outstanding:

SENS Cash Flow

Enable JavaScript and reload
Operating Activities Net Income:
Depreciation, Depletion & Amortization:
Change in Accounts Receiveable:
Net Cash from Operations:
Net Cash from Operations Per Share:
Repurchases/Buybacks Common Stock:
Issuance of Long-term Debt:
Cash Dividends Paid:
Net Cash from Financing Activities:
Property, Plant & Equipment Purchases:
Purchases of Businesses, Net of Cash:
Net Cash from Investing Activities:
Net Change in Cash & Equivalents:

SENS Balance Sheet

Enable JavaScript and reload
Cash and Cash Equivalents:
Short-Term Investments:
Accounts Receivable, Net:
Inventories:
Total Current Assets:
Property, Plant & Equipment, Net:
Total Assets:
Accounts Payable:
Current Portion of Long-Term Debt:
Total Short-Term Liabilities:
Long Term Debt, Non-Current Portion:
Total Long-Term Liabilities:
Total Liabilities:

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group
22,369,324 sh
129,319 sh
1%
$12,752
-$679
Blackrock.
12,161,140 sh
568,253 sh
5%
$6,933
-$69
Masters Capital Management
7,000,000 sh
 
$3,991
Geode Capital Management
5,402,197 sh
467,880 sh
9%
$3,080
$99
Charles Schwab Investment Management
2,999,250 sh
571,376 sh
24%
$1,710
$244
State Street
1,765,815 sh
 
$1,007
AXA
1,198,600 sh
 
$683
Northernrp
998,591 sh
61,524 sh
7%
$569
$3
Renaissance Technologies
912,100 sh
912,100 sh
NEW
$1
$1
Millennium Management
909,977 sh
-4,888,105 sh
-84%
$519
-$2,982
Susquehanna International Group,
839,315 sh
524,015 sh
166%
$479
$290
Citadel Advisors
775,050 sh
683,950 sh
751%
$442
$387
Mirae Asset Global Investments Co.,.
698,803 sh
-199,301 sh
-22%
$398
-$144
Point72 Asset Management, L.P.
614,166 sh
247,466 sh
67%
$350
$70
Wells Fargompany/Mn
453,436 sh
76,668 sh
20%
$258
$31
Citadel Advisors
Call options for 397,700 sh
397,700 sh
NEW
$227
$227
Cantor Fitzgerald, L. P.
366,938 sh
363,900 sh
11978%
$641
$217
Point72 Asset Management, L.P.
Call options for 366,700 sh
366,700 sh
NEW
$209
$209
Cubist Systematic Strategies
327,916 sh
-1,034,147 sh
-76%
$187
-$852
Price T Rowe Associates /Md/
316,200 sh
98,300 sh
45%
$0
COMPANY PROFILE
​ 1. Organization and Nature of Operations ​ Senseonics Holdings, Inc., a Delaware corporation, is a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (“CGM”) systems to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Senseonics, Incorporated is a wholly owned subsidiary of Senseonics Holdings, Inc. and was originally incorporated on October 30, 1996 and commenced operations on January 15, 1997. Senseonics Holdings, Inc. and Senseonics, Incorporated are hereinafter collectively referred to as the “Company” unless otherwise indicated or the context otherwise requires.

Free historical financial statements for Senseonics Holdings Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 32 quarters since 2016. Compare with SENS stock chart to see long term trends.

Data imported from Senseonics Holdings Inc SEC filings. Check original filings before making any investment decision.